Sarasin & Partners’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$170M Sell
1,858,052
-639,036
-26% -$55.9M 2% 18
2026
Q1
$213M Sell
2,497,088
-1,850,680
-43% -$165M 2.6% 15
2025
Q4
$344M Buy
4,347,768
+141,405
+3% +$11.1M 3.57% 7
2025
Q3
$338M Buy
4,206,363
+103,604
+3% +$8.84M 3.32% 8
2025
Q2
$373M Buy
4,102,759
+228,166
+6% +$20.8M 3.71% 7
2025
Q1
$363M Buy
3,874,593
+336,737
+10% +$30.2M 3.94% 9
2024
Q4
$322M Buy
3,537,856
+571,131
+19% +$54.5M 3.55% 12
2024
Q3
$308M Sell
2,966,725
-261,490
-8% -$26.7M 2.91% 15
2024
Q2
$313M Sell
3,228,215
-717,390
-18% -$66.2M 2.78% 14
2024
Q1
$355M Sell
3,945,605
-108,029
-3% -$9.15M 3.5% 9
2023
Q4
$323M Buy
4,053,634
+49,980
+1% +$3.76M 3.55% 7
2023
Q3
$285M Buy
4,003,654
+176,914
+5% +$13.2M 3.56% 9
2023
Q2
$295M Sell
3,826,740
-3,591,740
-48% -$278M 3.42% 7
2023
Q1
$597M Buy
7,418,480
+4,859,184
+190% +$361M 3.22% 6
2022
Q4
$202M Buy
2,559,296
+53,489
+2% +$4.01M 2.64% 12
2022
Q3
$176M Sell
2,505,807
-909,055
-27% -$71.3M 2.44% 15
2022
Q2
$274M Sell
3,414,862
-728,439
-18% -$57M 3.45% 7
2022
Q1
$314M Sell
4,143,301
-127,768
-3% -$10.1M 3.16% 11
2021
Q4
$364M Buy
4,271,069
+103,114
+2% +$8.05M 3.32% 5
2021
Q3
$315M Buy
4,167,955
+231,583
+6% +$18.4M 3.18% 6
2021
Q2
$320M Buy
3,936,372
+512,481
+15% +$41.9M 3.34% 6
2021
Q1
$270M Buy
3,423,891
+183,821
+6% +$14.4M 3.18% 10
2020
Q4
$277M Sell
3,240,070
-193,719
-6% -$16M 3.67% 4
2020
Q3
$265M Buy
3,433,789
+128,604
+4% +$9.81M 3.83% 1
2020
Q2
$242M Buy
3,305,185
+436,889
+15% +$31M 3.87% 2
2020
Q1
$190M Sell
2,868,296
-186,929
-6% -$13.2M 3.74% 4
2019
Q4
$210M Buy
3,055,225
+98,158
+3% +$6.69M 3.21% 7
2019
Q3
$217M Buy
2,957,067
+101,340
+4% +$7.35M 3.6% 5
2019
Q2
$205M Buy
2,855,727
+415,789
+17% +$29.5M 3.58% 5
2019
Q1
$167M Buy
2,439,938
+176,051
+8% +$11.4M 3.22% 10
2018
Q4
$135M Sell
2,263,887
-25,864
-1% -$1.62M 2.93% 13
2018
Q3
$153M Sell
2,289,751
-352,147
-13% -$23.5M 2.89% 11
2018
Q2
$171M Buy
2,641,898
+25,052
+1% +$1.64M 3.37% 7
2018
Q1
$188M Buy
2,616,846
+4,509
+0.2% +$324K 3.67% 4
2017
Q4
$197M Buy
2,612,337
+87,765
+3% +$6.41M 3.83% 3
2017
Q3
$184M Sell
2,524,572
-100,466
-4% -$7.24M 3.71% 3
2017
Q2
$195M Sell
2,625,038
-72,633
-3% -$5.39M 3.81% 2
2017
Q1
$197M Sell
2,697,671
-438,399
-14% -$30.7M 3.84% 2
2016
Q4
$205M Buy
3,136,070
+111,283
+4% +$7.63M 3.47% 2
2016
Q3
$224M Buy
3,024,787
+286,850
+10% +$21.2M 3.52% 4
2016
Q2
$200M Buy
2,737,937
+279,367
+11% +$19.9M 3.33% 6
2016
Q1
$174M Buy
2,458,570
+600,457
+32% +$39.9M 2.83% 10
2015
Q4
$124M Buy
1,858,113
+299,971
+19% +$20M 2.06% 17
2015
Q3
$98.9M Buy
1,558,142
+251,164
+19% +$16.4M 1.78% 20
2015
Q2
$85.5M Buy
1,306,978
+228,916
+21% +$15.5M 1.4% 25
2015
Q1
$74.8M Buy
1,078,062
+124,859
+13% +$8.63M 1.14% 31
2014
Q4
$66M Buy
953,203
+660,998
+226% +$44.6M 0.99% 34
2014
Q3
$19.1M Sell
292,205
-122,961
-30% -$8.11M 0.26% 57
2014
Q2
$28.3M Buy
415,166
+32,035
+8% +$2.15M 0.4% 51
2014
Q1
$24.9M Buy
383,131
+339,158
+771% +$21.4M 0.35% 47
2013
Q4
$2.87M Buy
+43,973
New +$2.81M 0.04% 111

Other funds holding CL

Sarasin & Partners's CL Position: Q2 2026 in Review

Sarasin & Partners reduced its Colgate-Palmolive (CL) stake by 26% in Q2 2026, selling an estimated $55.9M and leaving 1,858,052 shares worth $170M. The position accounts for 2% of the portfolio, ranked #18.

Sarasin & Partners first reported a position in CL in Q4 2013 and has held it in 51 quarters since. The position peaked at $597M in Q1 2023. 597 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Sarasin & Partners held 1,858,052 shares of Colgate-Palmolive worth $170M as of Q2 2026.
  • Sarasin & Partners sold 639,036 Colgate-Palmolive shares in Q2 2026, an estimated $55.9M.
  • Colgate-Palmolive made up 2% of Sarasin & Partners's portfolio in Q2 2026, its #18 holding.
  • Sarasin & Partners first reported a position in Colgate-Palmolive in Q4 2013 and has held it in 51 quarters since.
  • Sarasin & Partners's Colgate-Palmolive position peaked at $597M in Q1 2023.
  • 597 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Sarasin & Partners's 13F filing for Q2 2026, filed 7 Jul 2026.